Sastasundar Ventures Limited

Web: sastasundarventures.com NSE: SASTASUNDR BSE: 533259 SECTOR: Healthcare - Healthcare Services

285 13(4%)

Volume

29k as on 23, Jun

Open

318

High

323

Low

315

272

VWAP

318

52 Week High

363

52 Week Low

230

Viand Research Rating

Quality Score

32/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

905

No. of Shares

3.18

P/E

-1134.14

P/B

3.55

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-0.31

ROCE

Profit Growth

Listing Date

05-Oct-10

Promoter Holding

74.84%

FII Holding

2.17%

DII Holding

2.6%

Price Chart

Price Performance

1 Week4%

1 Month10%

3 Months15%

6 Months13%

1 Year13%

YTD13%

Moving Average

5 Day SMA317

10 Day SMA303

20 Day SMA304

30 Day SMA299

50 Day SMA290

61 Day SMA286

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	327	317	324	326
Resistance 2	324	317	322	324
Resistance 1	320	316	320	319
Pivot Point	317	316	317	317
Support 1	313	315	315	313
Support 2	311	314	313	310
Support 3	306	314	311	306

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.21) 74.84%	(0.51) 74.69%	(0.01) 74.24%	(0.11) 74.24%	(0.21) 74.11%	(0.01) 73.93%	(0.01) 73.92%	(0.01) 73.92%	(0.01) 73.92%	(0.01) 73.92%	(0.01) 73.92%	(0.01) 73.92%	(0.01) 73.92%	(0.01) 73.92%	(0.01) 73.92%	(0.21) 73.92%	(0.01) 73.72%	(-0.71) 73.72%	(0.01) 74.43%
FIIs	(-0.11) 2.17%	(0.21) 2.25%	(0.21) 2.04%	(0.31) 1.88%	(-0.11) 1.60%	(0.71) 1.71%	(0.41) 0.99%	(0.01) 0.61%	(0.11) 0.56%	(0.21) 0.49%	(0.01) 0.32%	(0.01) 0.31%	(0.11) 0.32%	(-0.21) 0.22%	(-0.11) 0.40%	(-0.11) 0.47%	(0.31) 0.52%	(0.21) 0.20%	(0.01) 0.02%
DIIs	(0.51) 2.60%	(0.01) 2.07%	(0.01) 2.07%	(0.01) 2.09%	(0.21) 2.06%	(-0.11) 1.85%	(0.61) 1.98%	(0.41) 1.35%	(0.11) 0.96%	(0.71) 0.86%	(0.01) 0.17%	(0.11) 0.17%	(0.01) 0.09%	(0.01) 0.09%	(0.01) 0.09%	(0.01) 0.09%	(0.01) 0.05%	(0.01) 0.02%	(0.01) 0.00%
Public	20.38%	20.99%	21.65%	21.79%	22.21%	22.50%	23.11%	24.12%	24.57%	24.73%	25.60%	25.60%	25.68%	25.78%	25.61%	25.52%	25.71%	26.06%	25.56%
No. of Shareholders	11,845	12,287	13,012	13,452	13,693	14,093	15,360	14,493	14,544	14,053	14,633	14,752	15,088	15,166	15,554	15,247	15,174	14,276	13,090

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	374	346	301	298	286	281	274	270	307	374	358	336	313	280.63	254	192	157	143	159	173
Sales Growth % (YoY)	30.8%	22.9%	10.2%	10.4%	-6.8%	-24.9%	-23.7%	-19.6%	-2.1%	33.4%	41%	75%	100%	96.8%	60%	10.8%	17.6%	4%	12.3%	27%
Sales Growth % (QoQ)	8.1%	15%	1%	4.2%	1.8%	2.6%	1.5%	-12.1%	-17.9%	4.5%	6.5%	7.3%	11.5%	10.5%	32.3%	22.3%	9.8%	-10.1%	-8.1%	-
Expenses	399	356	324	292	311	305	278	273	317	371	355	327	324	290.71	261	208	182	156	169	178
Operating Profit	-25	-10	-23	6	-25	-24	-5	-2	-11	3	3	9	-11	-10.08	-6	-16	-25	-13	-10	-5
OPM %	-7	-3	-8	2	-9	-8	-2	-1	-3	1	1	3	-4	-3.59	-2	-9	-16	-9	-6	-3
Other Income	13	14	5	25	22	-14	-167	29	18	20	10	12	9	4.01	-2	5	-7	1172	4	1
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0.27	0	0	0	0	1	0
Depreciation	2	2	1	1	1	1	1	2	3	2	2	2	3	2.4	2	1	1	1	1	1
Profit before tax	-15	1	-19	30	-5	-39	-174	25	5	21	11	19	-6	-8.74	-11	-12	-34	1157	-8	-6
Tax %	-12	60	-17	12	-478	2	-13	-103	-583	4	-23	-29	288	-70.48	-273	-32	-24	12	13	14
Net Profit	-13	0	-15	27	18	-38	-155	41	22	-3	-12	0	-48	-26.37	-3	-22	-26	1024	-9	-6
Net Profit Growth % (QoQ)	100%	100%	-155.6%	50%	147.4%	75.5%	-478%	86.4%	833.3%	75%	100%	100%	-82%	-779%	86.4%	15.4%	-102.5%	11477.8%	-50%	-
Net Profit Growth % (YoY)	-172.2%	100%	90.3%	-34.1%	-18.2%	-1166.7%	-1191.7%	100%	145.8%	88.6%	-300%	100%	-84.6%	-102.6%	66.7%	-266.7%	-	-	-	-
TTM Net Profit	-1	30	-8	-148	-134	-130	-95	48	7	-63	-86.37	-77.37	-99.37	-77.37	973	967	983	1009	-15	0
EPS in Rs	-3.51	0.36	-3.99	7.52	4.3	-8.47	-34.39	9.79	5.17	-0.24	-2.55	0.41	-10.75	-6	-0.39	-5.56	-6.07	232.31	-1.43	-1.14

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1319	1159	1432	1060	1798	551	388	222	162	135	89	52	30	47
Sales Growth %	13.9%	-19.1%	35%	-41%	226.5%	42%	74.8%	37.1%	19.9%	52.3%	69.7%	72.4%	-36.1%	-18.2%
Expenses	1371	1177	1456	1168	684	561	440	255	175	155	116	62	35	32
Operating Profit	-52	-19	-24	-107	1114	-10	-52	-33	-13	-20	-28	-10	-4	15
OPM %	-4	-2	-2	-10	62	-2	-13	-15	-8	-15	-31	-19	-15	33
Other Income	57	-179	4	-5	3	1	1	0	7	2	0	2	0	0
Interest	1	0	1	2	3	3	1	3	1	3	2	1	1	1
Depreciation	7	6	9	8	4	4	5	6	6	7	7	6	2	2
Profit before tax	-2	-204	-30	-122	1109	-16	-58	-42	-12	-28	-37	-15	-7	13
Tax %	-39	-34	-119	-19	22	4	-9	3	19	2	-1	0	-5	31
Net Profit	-1	-134	6	-99	865	-17	-52	-43	-15	-29	-37	-15	-6	8
Net Profit Growth %	99.3%	-2333.3%	106.1%	-111.4%	5188.2%	67.3%	-20.9%	-186.7%	48.3%	21.6%	-146.7%	-150%	-175%	-
EPS in Rs	0.37	-28.66	2.79	-22.7	197.05	-3.27	-12.19	-11.81	-3.73	-9	-11.51	-4.68	-2.03	2.58
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	-74	-17	36	-112	-207	-31	-69	-30	-49	-2	-12	-12	36	38
Cash from Investing Activity	171	-1	-34	133	220	21	-22	-2	15	4	-1	7	-42	-8
Cash from Financing Activity	-80	0	-2	-2	-11	4	103	26	33	5	13	4	-3	-19
Net Cash Flow	18	-19	0	19	1	-5	11	-6	-2	7	0	-1	-10	11

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32
Reserves	609	650	638	657	731	722	795	168	178	111	144	163	186	223	238	245
Borrowings	26	5	1	1	4	9	2	12	8	2	12	21	19	5	0	3
Other Liabilities	269	321	300	315	383	441	449	80	98	86	48	35	20	22	39	35
Total Liabilities	936	1008	970	1005	1149	1204	1278	293	316	230	235	251	256	281	309	315
Fixed Assets	117	117	102	104	110	107	93	110	114	116	117	125	126	137	117	94
CWIP	1	1	10	1	0	1	0	0	0	1	1	0	0	3	0	8
Investments	519	633	575	466	676	513	666	43	56	36	46	17	10	22	41	64
Other Assets	299	257	283	434	363	583	518	139	146	77	71	110	120	119	151	148
Total Assets	936	1008	970	1005	1149	1204	1278	293	316	230	235	251	256	281	309	315

Delivery

Daily Market Cap

No records found.

Stock Checklist

Price is below from 52 week high low average: 18%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView